Have you been diagnosed with Crohn's Disease?
This page is dedicated to the recruitment of participants for a clinical trial treatment for moderately to severely active Crohn’s Disease to be conducted by the University of the Sunshine Coast (QLD).
Full title: A Phase III, randomized, double blind, placebo-controlled, multi-centre study to evaluate the efficacy and safety of etrolizumab as an induction and maintenance treatment for patients with moderately to severely active Crohn’s Disease.
You are invited to complete a pre-assessment for this research project. This is because you have been diagnosed with Crohn’s Disease.
The research project is testing the safety and effectiveness of a potential new treatment for patients with moderately to severely active Crohn’s Disease. Please complete the following survey to express interest in participating in the above-mentioned trial.
Please be aware that completion of the survey does not guarantee entry into the trial.
Ethics approval – Bellberry Limited
If you experience difficulty completing the survey please email email@example.com or call 07 5456 3797.
Coastal Digestive Health
503/5 Emporio Place
MAROOCHYDORE QLD 4558